Structural and functional characterization of yellow field pea seed (Pisum sativum L.) protein-derived antihypertensive peptides

Food Research International

Volumn 77, Issue , 2015, Pages 10-16

  Aluko, Rotimi E ^a,b   Girgih, Abraham T ^a,b   He, Rong ^a,b,d   Malomo, Sunday ^a,b   Li, Huan ^a,b   Offengenden, Marina ^c   Wu, Jianping ^c  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d NANJING UNIVERSITY OF FINANCE AND ECONOMICS   (China)

Author keywords

Angiotensin converting enzyme; Antihypertensive peptides; Pea seed; Protein hydrolysate; Renin; Spontaneously hypertensive rats

Indexed keywords

BLOOD PRESSURE; ENZYMES; HYDROLYSIS; MASS SPECTROMETRY; PROTEINS; RATS;

ANGIOTENSIN-CONVERTING ENZYME; ANTIHYPERTENSIVE PEPTIDES; PROTEIN HYDROLYSATE; RENIN; SPONTANEOUSLY HYPERTENSIVE RATS;

PEPTIDES;

EID: 84943659797     PISSN: 09639969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodres.2015.03.029     Document Type: Article

References (40)

1. Abassi Z., Winaver J., Feuerstein G.Z. The biochemical pharmacology of renin inhibitors: Implications for translational medicine in hypertension, diabetic nephropathy and heart failure: expectations and reality. Biochemical Pharmacology 2009, 78:933-940.
2. Acharya K.R., Sturrock E.D., Riordan J.F., Ehlers M.R.W. ACE revisited: A new target for structure-based drug design. Nature Reviews Drug Discovery 2003, 2:891-902.
3. Alashi A.M., Blanchard C.L., Mailer R.J., Agboola S.O., Mawson A.J., He R., et al. Blood pressure lowering effects of Australian canola protein hydrolysates in spontaneously hypertensive rats. Food Research International 2014, 55:281-287.
4. Bas M., Adams V., Suvorava T., Niehues T., Hoffmann T.K., Kojda G. Nonallergic angioedema: Role of bradykinin. Allergy 2007, 62:842-856.
5. Belova L.A. Angiotensin II-generating enzymes. Biochemistry (Moscow) 2000, 65:1337-1345.
6. Chen J., Liu S., Ye R., Cai G., Ji B., Wu Y. Angiotensin-I converting enzyme (ACE) inhibitory tripeptides from rice protein hydrolysate: Purification and characterization. Journal of Functional Foods 2013, 5:1684-1692.
7. Cushman D.W., Ondetti M.A. Design of angiotensin converting enzyme inhibitors. Nature Medicine 1999, 10:1110-1113.
8. Fuchs S., Xiao H.D., Hubert C., Michaud A., Campbell D.J., Adams J.W., et al. Angiotensin-converting enzyme C-terminal catalytic domain is the main site of angiotensin I cleavage in vivo. Hypertension 2008, 51:267-274.
9. García-Tejedor A., Sánchez-Rivera L., Castelló-Ruiz M., Recio I., Salom J.B., Manzanares P. Novel antihypertensive lactoferrin-derived peptides produced by Kluyveromyces marxianus: Gastrointestinal stability profile and in vivo angiotensin I-converting enzyme (ACE) inhibition. Journal of Agricultural and Food Chemistry 2014, 62:1609-1616.
10. Girgih A.T., Alashi A.M., He R., Malomo S.A., Aluko R.E. Preventive and treatment effects of hemp seed (Cannabis sativa L.) meal protein hydrolysate against high blood pressure in spontaneously hypertensive rats. European Journal of Nutrition 2014, 53:1237-1246.
11. Girgih A.T., He R., Malomo S.A., Offengenden M., Wu J., Aluko R.E. Structural and functional characterization of hemp seed (Cannabis sativa L.) protein-derived antioxidant and antihypertensive peptides. Journal of Functional Foods 2014, 6:384-394.
12. Girgih A.T., He R., Aluko R.E. Kinetics and molecular docking studies of the inhibitions of angiotensin converting enzyme and renin activities by hemp seed (Cannabis sativa L.) peptides. Journal of Agricultural and Food Chemistry 2014, 62:4135-4144.
13. Girgih A.T., Udenigwe C.C., Li H., Adebiyi A.P., Aluko R.E. Kinetics of enzyme inhibition and antihypertensive effects of hemp seed (Cannabis sativa L.) protein hydrolysates. Journal of the American Oil Chemists' Society 2011, 88:1767-1774.
14. He R., Alashi A., Malomo S.A., Girgih A.T., Chao D., Ju X., et al. Antihypertensive and free radical scavenging properties of enzymatic rapeseed protein hydrolysates. Food Chemistry 2013, 141:153-159.
15. He R., Malomo S.A., Girgih A.T., Ju X., Aluko R.E. Glycinyl-histidinyl-serine (GHS), a novel rapeseed protein-derived peptide has blood pressure-lowering effect in spontaneously hypertensive rats. Journal of Agricultural and Food Chemistry 2013, 61:8396-8402.
16. He R., Malomo S.A., Alashi A., Girgih A.T., Ju X., Aluko R.E. Purification and hypotensive activity of rapeseed protein-derived renin and angiotensin converting enzyme inhibitory peptides. Journal of Functional Foods 2013, 5:781-789.
17. Huang W.-H., Sun J., He H., Dong H.-W., Li J.-T. Antihypertensive effect of corn peptides, produced by a continuous production in enzymatic membrane reactor, in spontaneously hypertensive rats. Food Chemistry 2011, 128:968-973.
18. Ishida Y., Shibata Y., Fukuhara I., Yano Y., Takehara I., Kaneko K. Effect of an excess intake of casein hydrolysate containing Val-Pro-Pro and Ile-Pro-Pro in subjects with normal blood pressure, high-normal blood pressure, or mild hypertension. Bioscience Biotechnology and Biochemistry 2011, 75:427-433.
19. Katayama K., Mori T., Kawahara S., Miake K., Kodama Y., Sugiyama M., et al. Angiotensin converting enzyme inhibitory peptide derived from porcine skeletal muscle myosin and its antihypertensive activity in spontaneously hypertensive rats. Journal of Food Science 2007, 72:S702-S706.
20. Li H., Prairie N., Udenigwe C.C., Adebiyi A.P., Tappia P., Aukema H.M., et al. Blood pressure lowering effect of a pea protein hydrolysate in hypertensive rats and humans. Journal of Agricultural and Food Chemistry 2011, 59:9854-9860.
21. Majumder K., Chakrabarti S., Morton J.S., Panahi S., Kaufman S., Davidge S.T., et al. Egg-derived tri-peptide IRW exerts antihypertensive effects in spontaneously hypertensive rats. PloS One 2013, 8:e82829.
22. Markwell M.A.K., Haas S.M., Bieber L.L., Tolbert N.E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Analytical Biochemistry 1978, 87:206-210.
23. Netesh R., Schwager S.L.U., Sturrock E.A.D., Acharya K.R. Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Nature 2003, 421:551-554.
24. Nishiyama A. Mechanisms responsible for renoprotective effects of renin-angiotensin inhibitors. Yakugaku Zasshi - Journal of the Pharmaceutical Society of Japan 2012, 132:455-459.
25. Peach M.J. Renin-angiotensin system: Biochemistry and mechanisms of action. Physiological Reviews 1997, 57:313-370.
26. Politi A., Durdagi S., Moutevelis-Minakakis P., Kokotos G., Mavromoustakos T. Development of accurate binding affinity predictions of novel renin inhibitors through molecular docking studies. Journal of Molecular Graphics and Modelling 2010, 29:425-435.
27. Pownall T.L., Udenigwe C.C., Aluko R.E. Amino acid composition and antioxidant properties of pea seed (Pisum sativum L.) enzymatic protein hydrolysate fractions. Journal of Agricultural and Food Chemistry 2010, 58:4712-4718.
28. Rahuel J., Rasetti V., Maibaum J., Rueger H., Goschke R., Cohen N.C., et al. Structure-based drug design: The discovery of novel nonpeptide orally active inhibitors of human renin. Chemistry & Biology 2000, 7:493-504.
29. Sánchez-Rivera L., Ares I., Miralles B., Gómez-Ruiz J.A., Recio I., Martínez-Larrañaga M.R., et al. Bioavailability and kinetics of the antihypertensive casein-derived peptide HLPLP in rats. Journal of Agricultural and Food Chemistry 2014, 62:11869-11875.
30. Sealey J.E., Laragh J.H. Aliskiren, the first renin inhibitor for treating hypertension: Reactive renin secretion may limit its effectiveness. American Journal of Hypertension 2007, 20:587-597.
31. Taylor A.A., Pool J.L. Clinical role of direct renin inhibition in hypertension. American Journal of Therapeutics 2012, 19:204-210.
32. Udenigwe C.C., Lin Y.-S., Hou W.-C., Aluko R.E. Kinetics of the inhibition of renin and angiotensin I-converting enzyme by flaxseed protein hydrolysate fractions. Journal of Functional Foods 2009, 1:199-207.
33. Waeber B., Nussberger J., Brunner H.R. Angiotensin-converting enzyme inhibitors in hypertension. Hypertension 1995, 2861-2875. Raven Press. J.H. Laragh, B.M. Brenner (Eds.).
34. Webb R.L., Schiering N., Sedrani R., Maibaum J. Direct renin inhibitors as a new therapy for hypertension. Journal of Medicinal Chemistry 2010, 53:7490-7520.
35. Wood J.M., Maibaum J., Rahuel J., Grutter M.G., Cohen N.C., Rasetti V., et al. Structure-based design of aliskiren, a novel orally effective renin inhibitor. Biochemical and Biophysical Research Communications 2003, 308:698-705.
36. Wu Y., Shi C., Sun X., Wu X., Sun H. Synthesis, biological evaluation and docking studies of octane-carboxamide based renin inhibitors with extended segments toward S3' site of renin. Bioorganic & Medicinal Chemistry 2011, 19:4238-4249.
37. Yamada A., Sakurai T., Ochi D., Mitsuyama E., Yamauchi K., Abe F. Novel angiotensin I-converting enzyme inhibitory peptide from bovine casein. Food Chemistry 2013, 141:3781-3789.
38. Yang Y., Marczak E.D., Yokoo M., Usui H., Yoshikawa M. Isolation and antihypertensive effect of angiotensin I-converting enzyme (ACE) inhibitory peptide from spinach Rubisco. Journal of Agricultural and Food Chemistry 2003, 51:4897-4902.
39. Yuan L., Wu J., Aluko R.E. Size of the aliphatic chain of sodium houttuyfonate analogs determines their affinity for renin and angiotensin I converting enzyme. International Journal of Biological Macromolecules 2007, 41:274-280.
40. Zaman M.A., Oparil S., Calhoun D.A. Drugs targeting the renin-angiotensin-aldosterone system. Nature Reviews Drug Discovery 2002, 1:621-636.